Coagulase-negative staphylococci (CoNS) are members of the normal human skin microflora and are the microorganisms most frequently isolated from clinical samples ([@B15]). CoNS are also the most common microorganisms identified in blood cultures of newborns in neonatal intensive care units (NICUs), causing 40-60% of the cases of bacteraemia ([@B18]).

The continued emergence of antimicrobial drug resistance is a serious problem for the antibiotic treatment of patients with staphylococcal infections in the clinic. Studies have reported that 60-85% of *Staphylococcus* strains isolated from clinical samples are resistant to methicillin ([@B17]). The major problem lies in the fact that infections caused by methicillin-resistant *Staphylococcus* strains are difficult to treat. In some cases, the isolates are only susceptible to glycopeptides and new drugs, such as linezolid, tigecycline, daptomycin and quinupristin/dalfopristin ([@B06], [@B22]).

The resistance of *Staphylococcus* species to oxacillin is mediated by the production of a supplemental penicillin-binding protein (PBP 2\' or PBP 2a) that has a low affinity for semi-synthetic penicillins. The protein is encoded by the *mecA* gene and this gene is identical in all *Staphylococcus* strains. Thus, *mecA* is a useful molecular marker of oxacillin resistance ([@B01]). The *mecA* gene is carried on a specific mobile genetic element, called the staphylococcal cassette chromosome *mec* (SCC*mec*). So far, 11 SCC*mec* types have been described in *Staphylococcus aureus* (IWG-SCC 2009). SCC*mec* types I, II and III are the most common in nosocomial isolates of oxacillin-resistant *Staphylococcus* strains, whereas the other types are characteristic of community-acquired strains. *SCCmec* type III encodes the largest number of resistance genes and is associated with serious hospital infections ([@B12]). In contrast, SCC*mec* type IV is small, more mobile and carries only genes that regulate the expression of the *mecA* gene ([@B11]).

As phenotypic methods for the detection of oxacillin-resistant - CoNS \[or methicillin-resistant CoNS (MRCoNS)\] strains may sometimes yield questionable results, molecular tests for the detection of the *mecA* gene have been proposed. Detection of the *mecA* gene by polymerase chain reaction (PCR) is the gold standard for the identification of oxacillin-resistant *Staphylococcus* and SCC*mec* typing by multiplex PCR permits the characterisation of the *Staphylococcus* species and the determination of susceptibility to different non-beta-lactam antibiotics. In this respect, the objective of the present study was to detect and characterise MRCoNS strains in blood cultures of newborns hospitalised in the NICU of the University Hospital, Faculty of Medicine (HC-FMB), **São Paulo State University (UNESP)**, Botucatu, state of São Paulo, Brazil.

This research was approved by the Research Ethical Committee (CEP) of the FMB (395/2005-CEP). The study was exempted from written informed consent from the study participants and/or their legal guardians because the samples of *Staphylococcus* included in the study were already isolated and stored in the Collection of Cultures of the Department of Microbiology and Immunology, UNESP.

One hundred CoNS strains isolated from blood cultures of newborns hospitalised in the NICU of HC-FMB/UNESP were studied in the period from 1990-2009. Samples representing the number of hospitalisations each year were randomly selected for the study. Phenotypic identification of the CoNS species was performed using biochemical tests according to the simplified method of Cunha et al. ([@B07]). PCR-based determination of internal transcribed spacer (ITS) regions was used for genotypic identification as according to Couto et al. ([@B05]) to confirm the phenotypic identification.

Susceptibility to oxacillin was tested by the agar diffusion method using impregnated disks based on the criteria of the Clinical and Laboratory Standards Institute (CLSI 2009). Oxacillin (1 µg) and cefoxitin (30 µg) disks were used. The international reference strains, *S. aureus* ATCC 25923 (oxacillin susceptible) and ATCC 33591 (oxacillin resistant), were used in all experiments. Screening medium consisting of Mueller-Hinton agar supplemented with 4 µg/mL oxacillin and 4% NaCl was used for the identification of oxacillin-resistant CoNS strains.

Oxacillin resistance was determined by detection of the *mecA* gene in the CoNS isolates. The primers and PCR conditions described by Murakami et al. ([@B20]) were used for the amplification procedure. *SCCmec* typing of the MRCoNS strains was performed by multiplex PCR. The primers and PCR conditions described by Oliveira and Lencastre ([@B21]) and modified by Machado et al. ([@B19]) were used for the amplification procedure.

One hundred CoNS strains were isolated from neonatal blood cultures. The phenotypic method identified 82% of the strains as *Staphylococcus epidermidis*, 7% as *Staphylococcus hominis*, 6% as *Staphylococcus haemolyticus*, 2% as *Staphylococcus lugdunensis*, 2% as *Staphy-lococcus warneri* and 1% as *Staphylococcus sapro-phyticus*. The genotypic method (PCR-ITS) identified 82% of the strains as *S. epidermidis*, 7% as *S. hominis*, 7% as *S. haemolyticus*, 2% as *S. lugdunensis*, 1% as *S. warneri* and 1% as *S. saprophyticus*.

The oxacillin (1 µg) disk diffusion method detected oxacillin resistance in 64% of the 100 CoNS strains studied. In contrast, 63% of the isolates were resistant when the cefoxitin (30 µg) disk test was used. Screening on Mueller-Hinton agar supplemented with 4% oxacillin and 4% NaCl demonstrated resistance to oxacillin in 64% of the CoNS isolates. The *mecA* gene was detected by PCR in 69 of the CoNS isolates, including 73.2% of *S. epidermidis* strains, 85.7% of *S. haemolyticus* strains, 28.6% of *S. hominis* strains and 50% of *S. lugdunensis* strains ([Table](#t01){ref-type="table"}). The oxacillin (1 µg) and cefoxitin (30 µg) disk diffusion methods had 92.8% and 91.3% sensitivity, respectively, and 100% specificity for the CoNS isolates studied. Sensitivity was 92.8% and specificity was 100% for the screening method.
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SCC*mec* typing was performed on all isolates carrying the *mecA* gene. Among these oxacillin-resistant CoNS strains, SCC*mec* type I was identified in 24.6%, type II in 4.3%, type III in 56.5% and type IV in 14.5% of the strains. Among the *S. epidermidis* strains resistant to oxacillin, 16.7% were characterised as SCC*mec* type I, 3.3% as type II, 63.3% as type III and 16.7% as type IV. Among the *S. haemolyticus* strains carrying the *mecA* gene, 83.3% were characterised as SCC*mec* type I and 16.7% as type II. The two oxacillin-resistant *S. hominis* isolates were characterised as SCC*mec* type I and the only *mecA*-positive *S. lugdunensis* isolate was found to be SCC*mec* type III ([Table](#t01){ref-type="table"}).

The CoNS strains studied were isolated from blood cultures of newborns hospitalised in the NICU of HC-FMB between 1990-2009. Thirty-one of these strains were isolated between 1990-1994 and 16 of them (51.6%) were resistant to oxacillin. Twenty-two strains were isolated between 1995-2002 and 14 (63.6%) were MRCoNS. Eighteen (78.3%) of the 23 strains isolated between 2003-2006 were resistant to oxacillin. During the last period studied (2007-2009), 24 strains were isolated and 21 (87.5%) were MRCoNS ([Fig. 1](#f01){ref-type="fig"}).

Fig. 1evolution of oxacillin resistance in coagulase-negative staphylococci strains in blood cultures of newborns hospitalised at the neonatal ward of the University Hospital, Faculty of Medicine, São Paulo State University, Botucatu, state of São Paulo, Brazil, between 1991-2009. MRCoNS: methicillin-resistant coagulase-negative staphylococci; MSCoNS: methicillin-susceptible coagulase-negative staphylococci.

Among the oxacillin-resistant CoNS strains isolated between 1990-1994, five (31.2%) were characterised as SCC*mec* type I, six (37.5%) were type III and five (31.2%) were type IV. Between 1995-2002, there were three (21.4%) SCC*mec* type I strains, 10 (71.4%) type III strains and one (7.2%) type IV strain. Among the strains isolated between 2003-2006, one (5.5%) was type I, three (16.7%) were type II, 11 (61.1%) were type III and three (16.7%) were type IV strains. During the last period (2007-2009), eight (38.1%) type I strains, 12 (57.1%) type III strains and one (4.8%) type IV strain were identified ([Fig. 2](#f02){ref-type="fig"}).

Fig. 2staphylococcal cassette chromosome mec type staphylococci strains in blood cultures of newborns hospitalised at the neonatal ward of the University Hospital, Faculty of Medicine, São Paulo State University, Botucatu, state of São Paulo, Brazil, between 1991-2009. MRCoNS: methicillin-resistant coagulase-negative staphylococci; MSCoNS: methicillin-susceptible coagulase-negative staphylococci.

The present study evaluated oxacillin resistance among the 100 CoNS strains isolated from blood cultures of newborns in the NICU of HC-FMB. The rate of oxacillin resistance among the CoNS strains isolated between 1990-2009 was 69%. High rates of oxacillin resistance among neonatal CoNS isolates have been reported by Hira et al. (2007), who observed that 87% of strains were MRCoNS. In a study conducted between 2005-2006 at a hospital in Porto Alegre, Brazil, 27 of the 57 strains identified as MRCoNS were isolated from the neonatal ward ([@B02]).

In the present study, 73.2% of the *S. epidermidis* isolates were resistant to oxacillin. Similar results have been reported by Krediet et al. ([@B16]), who found that 97% of *S. epidermidis* isolates from an NICU between 1999-2001 were oxacillin resistant. Although *S. epidermidis* was the most prevalent CoNS member and had the highest rate of resistance among the MRCoNS species studied, other resistant species were also identified. Oxacillin resistance was detected in 85.7% of *S. haemolyticus* strains. According to Ferreira et al. ([@B08]), 96% of *S. haemolyticus* strains isolated in Brazil are resistant to oxacillin and *S. haemolyticus* species are the second most prevalent nosocomial MRCoNS. The *mecA* gene was detected in 28.6% of the *S. hominis* strains studied here. This species has been associated with high rates of methicillin resistance, as 100% of isolates from an NICU in Spain were methicillin resistant ([@B03]). The first report of the *mecA* gene in *S. lugdu-nensis* was published by Kawaguchi et al. ([@B14]), who detected the gene in one of two isolates obtained from a neonatal ward. In the present study, *S. lugdunensis* was also isolated from two samples and one of the strains was resistant to oxacillin. According to Tee et al. ([@B23]), the identification of *S. lugdunensis* is important not only because of the clinical implications of this species as the most aggressive CoNS strain, but also for determination of oxacillin susceptibility so that early treatment with adequate antibiotics can be initiated and good clinical outcome can be guaranteed.

SCC*mec* typing permitted the differentiation of types I-IV among the oxacillin-resistant CoNS strains studied. SCC*mec* type I was detected in 24.6% of the oxacillin-resistant CoNS strains and type II was found in 4.3% of the strains. SCC*mec* type III was found in 56.5% of the MRCoNS isolates and was the most prevalent among the species studied. Similar results have been reported in a Brazilian study conducted by Machado et al. ([@B19]), who characterised MRCoNS species and revealed the presence of SCC*mec* type I in 28%, type II in 3% and type III in 52% of the strains. Whereas SCC*mec* type I contains only the *mecA* resistance gene, type II carries multiple resistance genes and has been associated with strains that began to be prevalent in the 1980s (Ito et al. 2001). Type III is the largest of the SCC*mec* types (66,896 bp) and encodes the largest number of resistance genes. This type is found in many hospital pathogens that can cause serious infections ([@B12]).

SCC*mec* type IV was identified in 14.5% of the MRCoNS strains studied. In contrast, Machado et al. ([@B19]) found that only 0.8% of MRCoNS strains carried SCC*mec* type IV. The smaller number of strains carrying *SCCmec* type IV, compared with the hospital types, most likely means an increase in its mobility and capacity of transfer between strains ([@B09]), suggesting that diseases caused by clones that carry SCC*mec* type IV will tend to increase ([@B19]). All strains carrying SCC*mec* type IV were identified as *S. epidermidis* and this type was detected in 15% of oxacillin-resistant strains. Types I-III were also found in *S. epidermidis* at frequencies of 16.7%, 3.3% and 63.3%, respectively. Similar results regarding the distribution of SCC*mec* among *S. epidermidis* strains have been reported by Machado et al. ([@B19]) with types I and IV found in 19% and 0.8%, respectively, whereas the percentage of type III was lower (41.8%). These authors did not detect type II in the *S. epidermidis* strains studied. The oxacillin-resistant *S. haemolyticus* strains carried SCC*mec* type I (83.3%) and type II (16.7%). SCC*mec* type I was detected in *S. hominis* strains and SCC*mec* type III was found in *S. lugdunensis*. These types are characteristic of nosocomial MRCoNS.

Analysis of the present data revealed an increase in the percentage of CoNS strains isolated from blood cultures during the period from 1991-2009. Furthermore, the results identified a predominant SCC*mec* profile of the oxacillin-resistant CoNS strains isolated from the NICU. There was a prevalence of SCC*mec* types found in hospital-acquired strains. SCC*mec* types I, III and IV were detected in MRCoNS isolates throughout the period studied and their proportion showed little variation, whereas type II was only detected in strains isolated between 2003-2006. The main limiting factor of the study is the uncertainty as to whether the isolates represent true infections, as no clinical data are presented. A certain percentage of isolates most likely represent skin contamination. Nevertheless, the percentage of MRCoNS strains is elevated and represents a matter of concern in terms of infection control practices in the neonatal ward of the HC-FMB.
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[^1]: *a*: 1µg disk diffusion method; *b*: 30µg disk diffusion method; *c*: on Mueller-Hinton agar supplemented with 4% oxacillin and 4% NaCl.
